Numenos

Clinico-Genomic Foundation Model

Health Tech & Life Sciences
Active
Seed Israel Founded 2023
Total raised
$5.0M
Last: Seed 2025-01
Stage
Seed
Founded
2023
Headcount
15
HQ
Israel
Sector
Health Tech & Life Sciences

About

Numenos is a techbio company that developed clinico-genomic foundation model.

Funding history · 1 round · $5.0M total

2025-01
Seed $5.0M

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is Numenos's core technology or product?
Numenos is a techbio company that developed a clinico-genomic foundation model.
When was Numenos founded?
Numenos was founded in January 2023.
Where is Numenos headquartered?
Numenos is headquartered in Israel.
Does Numenos have any international offices?
Yes, Numenos has an office in New York, NY, USA.
What is Numenos's primary industry sector?
Numenos operates in the Health Tech & Life Sciences sector.
How many employees does Numenos currently have?
Numenos currently has between 11 and 50 employees.
What was Numenos's most recent funding round?
In January 2025, Numenos completed a Seed funding round, raising a total of $5,000,000. TechAviv Founder Partners was a lead investor in this round.
Who are the founders of Numenos?
The founders of Numenos are Vitalay Fomin and Amit Weiss.
What is the current stage of Numenos?
Numenos is currently in the Seed stage.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life Sciences

Tags

healthcare